From: Effect of diet and omega-3 fatty acid intervention on asymmetric dimethylarginine
placebo (corn oil) | n-3 PUFA | ||||
---|---|---|---|---|---|
Baseline (n = 139) | 36 Months (n = 114) | Baseline (n = 139) | 36 Months (n = 122) | p | |
Linoleic acid, 18:2n-6 | 1.59 (1.33, 1.82) | 1.58 (1.36, 1.81) | 1.70 (1.47, 1.96) | 1.47 (1.24, 1.70)b | <0,001 |
AA, 20:4n-6 | 0.23 (0.20, 0.27) | 0.25 (0.21, 0.30)b | 0.22 (0.19, 0.27) | 0.21 (0.18, 0.25)b | <0,001 |
ALA, 18:3n-3 | 0.030 (0.022, 0. 39) | 0.031 (0.024, 0.037) | 0.033 (0.026, 0.043) | 0.031 (0.025, 0.042) | ns |
EPA, 20:5n-3 | 0.076 (0.049, 0.13) | 0.070 (0.041, 0.11)a | 0.081 (0.051, 0.14) | 0.22 (0.17, 0.27)b | <0,001 |
DHA, 22:6n-3 | 0.14 (0.12, 0.19) | 0.14 (0.11, 0.18) | 0.17 (0.12, 0.20) | 0.20 (0.16, 0.23)b | <0,001 |
Sum n-6 | 1.82 (1.57, 2.11) | 1.86 (1.58, 2.06) | 1.94 (1.68, 2.22) | 1.68 (1.44, 1.94)b | <0,001 |
Sum n-3 | 0.27 (0.20, 0.38) | 0.26 (0.21, 0.35) | 0.31 (0.22, 0.41) | 0.49 (0.39, 0.57)b | <0,001 |
Ratio omega-6/omega-3 | 6.85 (4.75, 9.27) | 7.08 (5.35, 9.44) | 6.36 (4.70, 8.37) | 3.40 (2.69, 4.28)b | <0,001 |
Total fatty acids in serum | 5.31 (4.58, 6.22) | 5.04 (4.40, 5.70) | 5.29 (4.60, 6.25) | 4.73 (4.05, 5.59)b | 0.011 |